Paper Details

  1. Home
  2. Paper Details

Effect of methimazole pretreatment on serum thyroid hormone levels after radioactive treatment in Graves' hyperthyroidism.

Author: AndradeV A, GrossJ L, MaiaA L

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study compared the effects of 131I treatment alone to 131I treatment with pretreatment with methimazole in patients with Graves' disease. The study found that interrupting antithyroid drugs before 131I administration caused a short-term increase in thyroid hormone levels.
Paper Details　
Original Abstract of the Article :
Radioiodine (131I) is the preferred definitive treatment for Graves' hyperthyroidism. Pretreatment with antithyroid drugs is often used to avoid thyroid hormone discharge after 131I ablation. However, this may represent an unnecessary increase in risk and costs. Fifty-one patients with Graves' disea...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1210/jcem.84.11.6149

データ提供：米国国立医学図書館（NLM）

Methimazole Pretreatment: Navigating the Shifting Sands of Thyroid Hormone Levels

Graves' hyperthyroidism, a condition characterized by an overactive thyroid gland, is like a desert oasis where the body's internal balance is disrupted. This study, like a seasoned desert traveler, explores the effects of methimazole pretreatment on thyroid hormone levels in patients undergoing radioactive treatment for Graves' hyperthyroidism.

The study investigates the impact of methimazole pretreatment on thyroid hormone levels in patients undergoing radioactive treatment for Graves' hyperthyroidism. The researchers found that interrupting methimazole prior to radioactive treatment led to a temporary increase in thyroid hormone levels, much like a desert mirage that shifts and changes over time. This study provides valuable insights into the dynamic changes in thyroid hormone levels during radioactive treatment, highlighting the importance of careful monitoring and individualized management approaches.

Methimazole Pretreatment: A Balancing Act in Thyroid Treatment

This study, like a camel caravan carefully navigating a shifting desert landscape, highlights the importance of understanding the dynamic changes in thyroid hormone levels during radioactive treatment. The findings suggest that careful monitoring and individualised management approaches are crucial for ensuring optimal outcomes in treating Graves' hyperthyroidism.

Finding the Right Path Through the Desert of Thyroid Treatment

Understanding the impact of methimazole pretreatment on thyroid hormone levels is crucial for successful treatment of Graves' hyperthyroidism. This study provides valuable insights into the complexities of managing this condition, offering a roadmap for navigating the shifting sands of thyroid hormone levels and achieving optimal outcomes for patients.

Dr. Camel's Conclusion

This study underscores the importance of understanding the dynamic changes in thyroid hormone levels during radioactive treatment for Graves' hyperthyroidism. The findings highlight the need for careful monitoring and individualised management approaches to navigate the shifting sands of thyroid hormone levels and achieve successful treatment outcomes for patients.

Date :
  1. Date Completed 1999-11-26
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

10566642

DOI: Digital Object Identifier

10.1210/jcem.84.11.6149

Related Literature

Article Analysis
・Effective treatment of hyperthyroidism
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.